Article info

Extended report
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register

Authors

  1. Correspondence to Dr Suzanne MM Verstappen, Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; suzanne.verstappen{at}manchester.ac.uk
View Full Text

Citation

Humphreys JH, Verheul MK, Barton A, et al
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register

Publication history

  • Received January 19, 2015
  • Revised June 29, 2015
  • Accepted July 6, 2015
  • First published October 6, 2015.
Online issue publication 
May 10, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Related Data

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.